CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients.
Madeddu, C;Pani, F;Massa, E;Scartozzi, M
2016-01-01
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.